The Value of Next-Generation Sequencing for Treatment in Non-Small Cell Lung Cancer Patients: The Observational, Real-World Evidence in China

BACKGROUND: Great success has been made in the targeting therapy of advanced non-small cell lung cancer (NSCLC). Nowadays, next generation sequencing (NGS) is acquirable and affordable in developed area of China. Using this feasible and accurate method of detecting therapeutic genes would help to se...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomed Res Int
Autors principals: Zhang, Yan, Shen, Wen-Xiang, Zhou, Li-Na, Tang, Min, Tan, Yue, Feng, Chun-Xia, Li, Ping, Wang, Li-Qiang, Chen, Min-Bin
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7003276/
https://ncbi.nlm.nih.gov/pubmed/32047821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/9387167
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars